Minimally Invasive Surgery Market (By Procedure, Disorder Type, End User: Hospitals, Ambulatory Surgical Centers, Clinics, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook and Forecast 2022 - 2030

Table of Contents

Chapter 1.           Introduction

1.1.    Research Objective

1.2.    Scope of the Study

1.3.    Definition

Chapter 2.           Research Methodology

2.1.    Research Approach

2.2.    Data Sources

2.3.    Assumptions & Limitations

Chapter 3.           Executive Summary

3.1.    Market Snapshot

Chapter 4.           Market Variables and Scope

4.1.    Introduction

4.2.    Market Classification and Scope

4.3.    Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel  Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5.           Market Dynamics Analysis and Trends

5.1.    Market Dynamics

5.1.1. Market Drivers

5.1.2. Market Restraints

5.1.3. Market Opportunities

5.2.    Porter’s Five Forces Analysis

5.2.1. Bargaining power of suppliers

5.2.2. Bargaining power of buyers

5.2.3. Threat of substitute

5.2.4. Threat of new entrants

5.2.5. Degree of competition

Chapter 6.           Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis

6.1.2. Key Strategies Adopted by Players

6.1.3. Vendor Landscape

6.1.3.1.              List of Suppliers

6.1.3.2.              List of Buyers

Chapter 7.           Global Minimally Invasive Surgery Market, By Procedure

7.1.    Minimally Invasive Surgery Market, by Procedure Type, 2021-2030

7.1.1. Laparoscopic Surgery

7.1.1.1.              Market Revenue and Forecast (2016-2030)

7.1.2. Robotic Surgery

7.1.2.1.              Market Revenue and Forecast (2016-2030)

7.1.3. Endoscopic Mucosal Resection

7.1.3.1.              Market Revenue and Forecast (2016-2030)

7.1.4. Endoscopic Sub-mucosal Dissection

7.1.4.1.              Market Revenue and Forecast (2016-2030)

Chapter 8.           Global Minimally Invasive Surgery Market, By End User

8.1.    Minimally Invasive Surgery Market, by End User, 2021-2030

8.1.1. Hospitals

8.1.1.1.              Market Revenue and Forecast (2016-2030)

8.1.2. Clinics

8.1.2.1.              Market Revenue and Forecast (2016-2030)

8.1.3. Ambulatory Surgical Centers

8.1.3.1.              Market Revenue and Forecast (2016-2030)

8.1.4. Others

8.1.4.1.              Market Revenue and Forecast (2016-2030)

Chapter 9.           Global Minimally Invasive Surgery Market, By Disorder

9.1.    Minimally Invasive Surgery Market, by Disorder, 2021-2030

9.1.1. Orthopedic

9.1.1.1.              Market Revenue and Forecast (2016-2030)

9.1.2. Cosmetic & Bariatric

9.1.2.1.              Market Revenue and Forecast (2016-2030)

9.1.3. Gynecological

9.1.3.1.              Market Revenue and Forecast (2016-2030)

9.1.4. Cardiothoracic

9.1.4.1.              Market Revenue and Forecast (2016-2030)

9.1.5. Gastrointestinal

9.1.5.1.              Market Revenue and Forecast (2016-2030)

9.1.6. Urological

9.1.6.1.              Market Revenue and Forecast (2016-2030)

9.1.7. Others

9.1.7.1.              Market Revenue and Forecast (2016-2030)

Chapter 10.       Global Minimally Invasive Surgery Market, Regional Estimates and Trend Forecast

10.1.North America

10.1.1.    Market Revenue and Forecast, by Procedure (2016-2030)

10.1.2.    Market Revenue and Forecast, by End User (2016-2030)

10.1.3.    Market Revenue and Forecast, by Disorder (2016-2030)

10.1.4.    U.S.

10.1.4.1.           Market Revenue and Forecast, by Procedure (2016-2030)

10.1.4.2.           Market Revenue and Forecast, by End User (2016-2030)

10.1.4.3.           Market Revenue and Forecast, by Disorder (2016-2030)

10.1.5.    Rest of North America

10.1.5.1.           Market Revenue and Forecast, by Procedure (2016-2030)

10.1.5.2.           Market Revenue and Forecast, by End User (2016-2030)

10.1.5.3.           Market Revenue and Forecast, by Disorder (2016-2030)

10.2.Europe

10.2.1.    Market Revenue and Forecast, by Procedure (2016-2030)

10.2.2.    Market Revenue and Forecast, by End User (2016-2030)

10.2.3.    Market Revenue and Forecast, by Disorder (2016-2030)

10.2.4.    UK

10.2.4.1.           Market Revenue and Forecast, by Procedure (2016-2030)

10.2.4.2.           Market Revenue and Forecast, by End User (2016-2030)

10.2.4.3.           Market Revenue and Forecast, by Disorder (2016-2030)

10.2.5.    Germany

10.2.5.1.           Market Revenue and Forecast, by Procedure (2016-2030)

10.2.5.2.           Market Revenue and Forecast, by End User (2016-2030)

10.2.5.3.           Market Revenue and Forecast, by Disorder (2016-2030)

10.2.6.    France

10.2.6.1.           Market Revenue and Forecast, by Procedure (2016-2030)

10.2.6.2.           Market Revenue and Forecast, by End User (2016-2030)

10.2.6.3.           Market Revenue and Forecast, by Disorder (2016-2030)

10.2.7.    Rest of Europe

10.2.7.1.           Market Revenue and Forecast, by Procedure (2016-2030)

10.2.7.2.           Market Revenue and Forecast, by End User (2016-2030)

10.2.7.3.           Market Revenue and Forecast, by Disorder (2016-2030)

10.3.APAC

10.3.1.    Market Revenue and Forecast, by Procedure (2016-2030)

10.3.2.    Market Revenue and Forecast, by End User (2016-2030)

10.3.3.    Market Revenue and Forecast, by Disorder (2016-2030)

10.3.4.    India

10.3.4.1.           Market Revenue and Forecast, by Procedure (2016-2030)

10.3.4.2.           Market Revenue and Forecast, by End User (2016-2030)

10.3.4.3.           Market Revenue and Forecast, by Disorder (2016-2030)

10.3.5.    China

10.3.5.1.           Market Revenue and Forecast, by Procedure (2016-2030)

10.3.5.2.           Market Revenue and Forecast, by End User (2016-2030)

10.3.5.3.           Market Revenue and Forecast, by Disorder (2016-2030)

10.3.6.    Japan

10.3.6.1.           Market Revenue and Forecast, by Procedure (2016-2030)

10.3.6.2.           Market Revenue and Forecast, by End User (2016-2030)

10.3.6.3.           Market Revenue and Forecast, by Disorder (2016-2030)

10.3.7.    Rest of APAC

10.3.7.1.           Market Revenue and Forecast, by Procedure (2016-2030)

10.3.7.2.           Market Revenue and Forecast, by End User (2016-2030)

10.3.7.3.           Market Revenue and Forecast, by Disorder (2016-2030)

10.4.MEA

10.4.1.    Market Revenue and Forecast, by Procedure (2016-2030)

10.4.2.    Market Revenue and Forecast, by End User (2016-2030)

10.4.3.    Market Revenue and Forecast, by Disorder (2016-2030)

10.4.4.    GCC

10.4.4.1.           Market Revenue and Forecast, by Procedure (2016-2030)

10.4.4.2.           Market Revenue and Forecast, by End User (2016-2030)

10.4.4.3.           Market Revenue and Forecast, by Disorder (2016-2030)

10.4.5.    North Africa

10.4.5.1.           Market Revenue and Forecast, by Procedure (2016-2030)

10.4.5.2.           Market Revenue and Forecast, by End User (2016-2030)

10.4.5.3.           Market Revenue and Forecast, by Disorder (2016-2030)

10.4.6.    South Africa

10.4.6.1.           Market Revenue and Forecast, by Procedure (2016-2030)

10.4.6.2.           Market Revenue and Forecast, by End User (2016-2030)

10.4.6.3.           Market Revenue and Forecast, by Disorder (2016-2030)

10.4.7.    Rest of MEA

10.4.7.1.           Market Revenue and Forecast, by Procedure (2016-2030)

10.4.7.2.           Market Revenue and Forecast, by End User (2016-2030)

10.4.7.3.           Market Revenue and Forecast, by Disorder (2016-2030)

10.5.Latin America

10.5.1.    Market Revenue and Forecast, by Procedure (2016-2030)

10.5.2.    Market Revenue and Forecast, by End User (2016-2030)

10.5.3.    Market Revenue and Forecast, by Disorder (2016-2030)

10.5.4.    Brazil

10.5.4.1.           Market Revenue and Forecast, by Procedure (2016-2030)

10.5.4.2.           Market Revenue and Forecast, by End User (2016-2030)

10.5.4.3.           Market Revenue and Forecast, by Disorder (2016-2030)

10.5.5.    Rest of LATAM

10.5.5.1.           Market Revenue and Forecast, by Procedure (2016-2030)

10.5.5.2.           Market Revenue and Forecast, by End User (2016-2030)

10.5.5.3.           Market Revenue and Forecast, by Disorder (2016-2030)

Chapter 11.       Company Profiles

11.1.University of Pittsburgh Medical Center

11.1.1.    Company Overview

11.1.2.    Product Offerings

11.1.3.    Financial Performance

11.1.4.    Recent Initiatives

11.2.Rutland Medical Center

11.2.1.    Company Overview

11.2.2.    Product Offerings

11.2.3.    Financial Performance

11.2.4.    Recent Initiatives

11.3.Huntington Hospital

11.3.1.    Company Overview

11.3.2.    Product Offerings

11.3.3.    Financial Performance

11.3.4.    Recent Initiatives

11.4.Washington Hospital Healthcare System

11.4.1.    Company Overview

11.4.2.    Product Offerings

11.4.3.    Financial Performance

11.4.4.    Recent Initiatives

11.5.The Ottawa Hospital

11.5.1.    Company Overview

11.5.2.    Product Offerings

11.5.3.    Financial Performance

11.5.4.    Recent Initiatives

11.6.Michael's Hospital

11.6.1.    Company Overview

11.6.2.    Product Offerings

11.6.3.    Financial Performance

11.6.4.    Recent Initiatives

11.7.Charité - Universitätsmedizin Berlin

11.7.1.    Company Overview

11.7.2.    Product Offerings

11.7.3.    Financial Performance

11.7.4.    Recent Initiatives

11.8.Ipswich Hospital

11.8.1.    Company Overview

11.8.2.    Product Offerings

11.8.3.    Financial Performance

11.8.4.    Recent Initiatives

11.9.Apollo Hospitals Enterprise Limited

11.9.1.    Company Overview

11.9.2.    Product Offerings

11.9.3.    Financial Performance

11.9.4.    Recent Initiatives

11.10.                  HealthCare Global Enterprises Ltd.

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12.       Research Methodology

12.1.Primary Research

12.2.Secondary Research

12.3.Assumptions

Chapter 13.       Appendix

13.1.About Us

13.2.Glossary of Terms

Report Details

  • Report Code:38100
  • Category:Healthcare
  • No. of Pages:150+
  • Format:PDF/PPT/Excel
  • Published:July 2022
  • Historical Year:2021-2022
  • Base Year:2023
  • Estimated Year:2024-2033

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers